Cannabis and the stock market

Aurora Cannabis drops shares in the Cann Group


Publicly listed medical cannabis company, The Cann Group, has lost a major investor after Aurora Cannabis sells its 11% stake in the company. 

The Cann Group Limited (ASX: CAN) was the first Australian company to receive it’s licensing and permit for the cultivation of medical cannabis in 2017. That year, Canadian-investor Aurora Cannabis first begun to invest in The Cann Group.

Aurora continued to invest over the next three years, sinking a total of AUD $32.4 million into group. On Friday, Aurora’s entire 11.84% stake was sold off market to a small handful of buyers. 

Based on the closing share price of $0.42, Aurora has estimated to have made $13.4 million from the sale. 

While Aurora has not issued a public statement explaining why their investment was dropped, the Cann Group’s 2019/2020 financial year results were released in August. The results show that the Cann Group’s revenue dropped 56% from the previous financial year, making just $1.86 million

Despite this, the company has reassured investors Aurora’s withdrawal will not impact the growth of the company. The following was stated in a press release: 

Aurora’s decision has no impact on Cann Group’s business plans, which remain focused on developing a growing and diversified supply base with B2B customers in Australia and overseas.

Among other large-scale projects, The Cann Group is currently building a $184 million cannabis production facility in Mildura. The company was granted a $1.975 million government grant for the facility in July. 

Stay informed with the latest cannabis news in Australia.


Latest from National

Stay informed with the latest cannabis news in Australia.

Stay informed with the latest cannabis news in Australia.

Go to Top